Potencies and Selectivities of Inhibitors of Acetylcholinesterase and Its Molecular Forms in Normal and Alzheimer’s Disease Brain
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1588-256X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Potencies and Selectivities of Inhibitors of Acetylcholinesterase and Its Molecular Forms in Normal and Alzheimer’s Disease Brain ; volume:54 ; number:2 ; day:30 ; month:12 ; year:2003 ; pages:183-189 ; date:6.2003
Acta biologica Hungarica ; 54, Heft 2 (30.12.2003), 183-189, 6.2003
- Creator
-
Rakonczay, Z.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1556/ABiol.54.2003.2.7
- URN
-
urn:nbn:de:101:1-2020100419474709762238
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:50 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Rakonczay, Z.
- SpringerLink (Online service)
Other Objects (12)
Acetylcholinesterase inhibitors and cognitive stimulation, combined and alone, in treating individuals with mild Alzheimer’s disease
Psychiatric Adverse Events of Acetylcholinesterase Inhibitors in Alzheimer’s Disease and Parkinson’s Dementia: Systematic Review and Meta-Analysis
Design, synthesis, in silico and biological evaluations of novel polysubstituted pyrroles as selective acetylcholinesterase inhibitors against Alzheimer’s disease
Association of the Choline Acetyltransferase Gene with Responsiveness to Acetylcholinesterase Inhibitors in Alzheimer’s Disease
Green synthesis of Kickxia elatine -induced silver nanoparticles and their role as anti-acetylcholinesterase in the treatment of Alzheimer’s disease
Expression and Distribution of Carboxypeptidase B in the Hippocampal Subregions of Normal and Alzheimer’s Disease Brain
Alzheimer’s disease neuropathological change and loss of matrix/neuropil in patients with idiopathic Normal Pressure Hydrocephalus, a model of Alzheimer’s disease
The duality of amyloid-β: its role in normal and Alzheimer’s disease states
EEG biomarkers in Alzheimer’s and prodromal Alzheimer’s: a comprehensive analysis of spectral and connectivity features
Myco-fabricated ZnO nanoparticles ameliorate neurotoxicity in mice model of Alzheimer’s disease via acetylcholinesterase inhibition and oxidative stress reduction
Molecular mechanisms and genetics of Alzheimer’s disease
Genomics and Functional Genomics of Alzheimer’s Disease
Acetylcholinesterase inhibitors and cognitive stimulation, combined and alone, in treating individuals with mild Alzheimer’s disease
Psychiatric Adverse Events of Acetylcholinesterase Inhibitors in Alzheimer’s Disease and Parkinson’s Dementia: Systematic Review and Meta-Analysis
Design, synthesis, in silico and biological evaluations of novel polysubstituted pyrroles as selective acetylcholinesterase inhibitors against Alzheimer’s disease
Association of the Choline Acetyltransferase Gene with Responsiveness to Acetylcholinesterase Inhibitors in Alzheimer’s Disease
Green synthesis of Kickxia elatine -induced silver nanoparticles and their role as anti-acetylcholinesterase in the treatment of Alzheimer’s disease
Expression and Distribution of Carboxypeptidase B in the Hippocampal Subregions of Normal and Alzheimer’s Disease Brain
Alzheimer’s disease neuropathological change and loss of matrix/neuropil in patients with idiopathic Normal Pressure Hydrocephalus, a model of Alzheimer’s disease
The duality of amyloid-β: its role in normal and Alzheimer’s disease states
EEG biomarkers in Alzheimer’s and prodromal Alzheimer’s: a comprehensive analysis of spectral and connectivity features
Myco-fabricated ZnO nanoparticles ameliorate neurotoxicity in mice model of Alzheimer’s disease via acetylcholinesterase inhibition and oxidative stress reduction
Molecular mechanisms and genetics of Alzheimer’s disease
Genomics and Functional Genomics of Alzheimer’s Disease
Acetylcholinesterase inhibitors and cognitive stimulation, combined and alone, in treating individuals with mild Alzheimer’s disease
Psychiatric Adverse Events of Acetylcholinesterase Inhibitors in Alzheimer’s Disease and Parkinson’s Dementia: Systematic Review and Meta-Analysis
Design, synthesis, in silico and biological evaluations of novel polysubstituted pyrroles as selective acetylcholinesterase inhibitors against Alzheimer’s disease
Association of the Choline Acetyltransferase Gene with Responsiveness to Acetylcholinesterase Inhibitors in Alzheimer’s Disease
Green synthesis of Kickxia elatine -induced silver nanoparticles and their role as anti-acetylcholinesterase in the treatment of Alzheimer’s disease
Expression and Distribution of Carboxypeptidase B in the Hippocampal Subregions of Normal and Alzheimer’s Disease Brain
Alzheimer’s disease neuropathological change and loss of matrix/neuropil in patients with idiopathic Normal Pressure Hydrocephalus, a model of Alzheimer’s disease
The duality of amyloid-β: its role in normal and Alzheimer’s disease states
EEG biomarkers in Alzheimer’s and prodromal Alzheimer’s: a comprehensive analysis of spectral and connectivity features
Myco-fabricated ZnO nanoparticles ameliorate neurotoxicity in mice model of Alzheimer’s disease via acetylcholinesterase inhibition and oxidative stress reduction
Molecular mechanisms and genetics of Alzheimer’s disease